Biosense Webster, Inc.
Clinical trials sponsored by Biosense Webster, Inc., explained in plain language.
-
New heart procedure tested for Long-Term control of irregular heartbeat
Disease control OngoingThis study is testing a specialized catheter (THERMOCOOL SMARTTOUCH®SF) guided by a measurement called Ablation Index for treating paroxysmal atrial fibrillation (a type of irregular heartbeat). It aims to see how well this procedure controls the irregular heartbeat and how safe …
Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated Apr 02, 2026 05:12 UTC
-
New heart implant aims to stop deadly strokes before they happen
Disease control TerminatedThis study is testing a new heart implant device designed to prevent strokes in people with a common heart rhythm problem called atrial fibrillation. The device seals off a small pouch in the heart where blood clots often form. Researchers will compare this new device to two alre…
Phase: NA • Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New heart device could offer lifeline for Stroke-Prone patients
Disease control OngoingThis early study is testing a small heart implant called the Laminar device. It aims to prevent strokes in people with a common heart rhythm problem (atrial fibrillation) who cannot safely take long-term blood thinners. Doctors will implant the device to seal off a small pouch in…
Phase: NA • Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC